DSCM Insider Trading Activity and SEC Form 4 Filings
DSCM insider trading summary
No open-market insider purchases or sales of Drugstore Com Inc (DSCM) have been reported on SEC Form 4 in the past 12 months.
Latest DSCM insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 25, 2011 | David Lawrence Lonczak | VP, Chief Marketing Officer | Sell | $195K (50,000 @ $3.90) |
| Mar 25, 2011 | David Lawrence Lonczak | VP, Chief Marketing Officer | Sell | $301K (77,142 @ $3.90) |
| Mar 25, 2011 | Kathleen McKey McNeill | VP, Beauty | Sell | $78K (20,000 @ $3.90) |
| Mar 24, 2011 | James Orville Steeb | Pres & CEO, Salu Beauty, Inc. | Sell | $612K (160,989 @ $3.80) |
| Aug 31, 2010 | Luke Thomas Friang | VP, Chief Information Officer | Sell | $35K (22,912 @ $1.53) |
| Aug 11, 2010 | Richard Wilson Bennet III | Director | Buy | $20K (10,000 @ $2.00) |
| Aug 10, 2010 | Jon Clarence Axelsson | VP, Operations | Buy | $2K (1,000 @ $2.10) |
| Aug 9, 2010 | Luke Thomas Friang | VP, Chief Information Officer | Buy | $8K (4,000 @ $2.10) |
| Aug 6, 2010 | Dawn G Lepore | CEO, Pres + Chairman of Board | Buy | $21K (10,000 @ $2.09) |
| Aug 6, 2010 | Tracy Lynn Wright | VP, Chief Finance Officer | Buy | $10K (5,000 @ $2.08) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.